Large-scale testing (Phase 3)Study completedNCT07626892
What this trial is testing
Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression
Who this might be right for
Myopia ProgressionAtropine
Khyber Medical College, Peshawar 95